Axon Enterprise, Inc.

Axon Enterprise, Inc. (AXON) Market Cap

Axon Enterprise, Inc. has a market capitalization of .

No quote data available.

CEO: Patrick W. Smith

Sector: Industrials

Industry: Aerospace & Defense

IPO Date: 2001-06-07

Website: https://www.axon.com

Axon Enterprise, Inc. (AXON) - Company Information

Market Cap: -|Sector: Industrials

Company Profile

Axon Enterprise, Inc., founded in 1993 and headquartered in Scottsdale, Arizona, was previously known as TASER International, Inc. until its rebranding in April 2017. The company specializes in the development, production, and sale of conducted energy devices (CEDs) marketed under its well-known TASER brand, catering to both domestic and international clients. Axon's operations are divided into two primary segments: TASER, and Software and Sensors. In addition to its signature TASER devices, such as the TASER 7, X26P, X2, and consumer models, along with their corresponding cartridges, Axon offers an extensive portfolio of hardware and cloud-based software. These solutions are designed to equip law enforcement agencies with the means to capture, securely archive, manage, share, and analyze video and other digital evidence. Key products in this category include on-officer body cameras, Axon Fleet in-car systems, the Axon Evidence digital evidence management platform, Axon Signal-enabled devices, extended hardware warranties, and vital accessories like docks, cartridges, and batteries. Axon distributes its offerings through multiple channels, including its dedicated direct sales force, various distribution partners, its online storefront, and authorized third-party resellers. Furthermore, the company has established a strategic partnership with Fusus, Inc. to enhance the functionality of Axon Respond and the Fusus Real Time Crime Center in the Cloud solution, providing agencies with real-time operational awareness and more efficient investigative processes.

Analyst Sentiment

81%
Strong Buy

From 22 Active Polls

1Y Forecast: $658.56

▲ +0.0% Potential Upside

Consensus Target Metrics

Low Bound

$440

Median

$724

High Bound

$820

Average

$659

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$658.56
▲ +24.78% Upside
Low Target
$440.00
-17% Risk
Median Target
$724.00
37% Mid
High Target
$820.00
55% Max

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

Sentiment volume allocation data unavailable.

Historical valuation matrix unavailable.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 AXON ENTERPRISE INC (AXON) — Investment Overview

🧩 Business Model Overview

Axon sells an integrated suite for public safety: conducted energy devices (“TASER” and related tools), body-worn cameras, associated in-car/mobile recording, and the software platform used to manage, store, and share evidence. The model is designed around an end-to-end workflow—capture hardware at the field level, automated upload from cameras and devices to a centralized system, and evidence management tools that support investigation, review, redaction, and sharing with external stakeholders (e.g., internal investigators, prosecutors, and courts).

Commercially, Axon is structured to move agencies from one-time equipment purchases toward multi-year agreements that bundle hardware, cloud evidence storage, analytics/tools, and ongoing software services. This pricing approach aligns incentives: customers pay for the operational outcomes of keeping evidence secure and accessible rather than buying standalone devices.

💰 Revenue Streams & Monetisation Model

Axon monetizes through (1) recurring software and services subscriptions tied to cloud evidence management and connected-device ecosystems, and (2) device-related revenue from core public safety hardware. Over time, the mix shifts toward higher recurring content as agencies expand fleets, add camera units, and increase usage of cloud storage and software modules.

Margin drivers are primarily subscription mix, platform utilization (more recorded events stored and processed in the evidence system), and hardware gross margin mechanics offset by ongoing support and infrastructure costs. As the installed base grows, Axon’s software platform can scale with incremental revenue per additional agency usage while maintaining a relatively efficient cost structure relative to purely transactional equipment models.

🧠 Competitive Advantages & Market Positioning

Axon’s most durable moat is high switching costs driven by data gravity and workflow lock-in. Evidence systems accumulate long-lived, legally sensitive data (video, metadata, case context, user permissions, audit trails, and integration configurations). Migrating away from an installed evidence management platform involves operational disruption, retraining, reconfiguration of evidentiary workflows, and substantial migration risk. These factors compound over multi-year deployments and create structural customer stickiness.

A second advantage is the integrated ecosystem across devices and software. Competitors may offer hardware or software, but Axon’s platform-centric approach aims to standardize how agencies capture, upload, classify, store, search, and share evidence—reducing friction for procurement and implementation teams.

Competitive benchmarking:

  • Motorola Solutions (public safety communications and video ecosystems) competes with integrated communications and select video offerings; Axon’s differentiation centers on the evidence management platform’s depth and the connected-device evidence workflow.
  • Digital Ally (body-worn and in-vehicle recording) competes more directly on hardware and standalone recording solutions; Axon’s focus remains on cloud evidence management and multi-year software-led agreements.
  • Verkada (cloud video systems) competes on modern, web-delivered video experiences; Axon’s positioning emphasizes public safety evidence workflows, long retention needs, and the breadth of investigative and evidence-sharing tooling.

Overall, rivals can win discrete procurements, but Axon’s challenge-and-response profile is shaped by installed-base economics: agencies weigh near-term device selection against long-term total cost of ownership and operational reliability of the evidence platform.

🚀 Multi-Year Growth Drivers

Axon’s addressable market expands through multiple secular forces that support durable device and software replacement cycles:

  • Public safety digitization: continued modernization of police and public safety operations drives adoption of body-worn and connected recording—especially where policy, training, and accountability standards require systematic capture.
  • Cloud evidence infrastructure: agencies increasingly prefer managed evidence platforms that reduce local storage burden, improve search and retrieval, and support secure access controls and retention.
  • Platform expansion within agencies: incremental camera/device additions, broader user access, and deeper evidence tooling adoption increase usage intensity on the same core platform.
  • Interoperability and workflow standardization: growth in integrations with case management and operational systems expands the platform’s embedded role in daily workflows.
  • Data-driven analytics uptake: lawful and operationally valuable analytics (e.g., workflow automation, review acceleration, tagging/search enhancements) can increase engagement and support continued subscription value.

Over a 5–10 year horizon, the investment case is less about one-off hardware cycles and more about the compounding effect of installed base growth, recurring software content, and long-duration evidence storage and management needs.

⚠ Risk Factors to Monitor

  • Government procurement and budget cyclicality: the customer base is concentrated in public agencies, where spending priorities and procurement timelines can affect conversion speed and contract renewals.
  • Regulatory and privacy constraints: changes in surveillance, retention, consent, and evidence-handling rules can require product modifications and can increase compliance costs or restrict data usage.
  • Technology disruption and platform substitution risk: competitors with alternative architectures or faster product cycles could pressure pricing or displace workflows, particularly if interoperability improves elsewhere.
  • Cybersecurity and operational reliability: evidence platforms contain sensitive data and must maintain high availability, robust access controls, and strong security practices to reduce breach and liability risk.
  • Concentrated contract economics: large agency wins and expansions can drive results, but contract renewals and expansion rates may vary by jurisdiction and policy environment.
  • Hardware supply chain and manufacturing execution: device demand requires consistent sourcing and production quality; execution issues can translate into service disruptions or warranty and replacement costs.

📊 Valuation & Market View

The market often values Axon with a blend of SaaS-like and infrastructure-like frameworks, reflecting a recurring revenue base alongside hardware-linked adoption. Common valuation lenses include:

  • EV/Revenue or P/S for early-to-mid stage visibility into subscription growth and platform adoption.
  • EV/ARR or revenue durability metrics where investors focus on recurring growth, retention, and the pace of software attach to the installed base.
  • EV/EBITDA as margins and operating leverage mature, emphasizing scale in cloud evidence operations and customer support.

Key valuation drivers typically include the sustainability of recurring revenue growth, evidence platform utilization, net retention dynamics within agencies, and the trajectory of operating leverage as fixed cloud and platform costs spread over the installed base.

🔍 Investment Takeaway

Axon’s long-term investment profile is anchored by switching-cost economics from evidence data gravity and workflow lock-in, supported by an integrated device-to-cloud ecosystem. With public safety modernization and cloud evidence management remaining multi-year priorities, Axon is positioned to compound recurring subscription value as agencies expand device fleets and deepen platform usage—while managing risks tied to government procurement cycles, privacy regulation, and cybersecurity requirements.


⚠ AI-generated — informational only. Validate using filings before investing.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"AXON reported Q1 2026 results with Revenue of $807.3M and Net Income of $169.3M (EPS $2.11). On a YoY basis, Revenue grew +33.7% (vs. $603.6M in Q1 2025) and Net Income rose from $87.98M to $169.31M (+92.3%). QoQ, Revenue edged up +1.4% (from $796.7M in Q4 2025) while Net Income jumped from $3.0M to $169.3M (+5,544.0%), indicating a strong normalization/turnaround versus the prior quarter. Gross margin improved slightly to 59.1% (vs. 57.9% in Q4), and net margin expanded materially to 21.0% (vs. 0.4% in Q4). Operating income increased to $29.2M (net operating margin 3.6%), showing a clear sequential improvement. Cash flow quality is mixed: operating cash flow was -$31.5M and free cash flow was -$54.6M, with significant investing outflows driven by acquisitions ($549.7M) and investment activity. Balance sheet resilience remains strong: total assets were $7.07B and equity $3.53B, up from Q4. Net debt increased to $1.37B, but liquidity is still substantial with $718.9M in cash & short-term investments. Shareholder returns are pressured—marketPerformance shows -29.6% over the last 1 year and no dividend activity—reducing total shareholder return momentum despite strong operating profitability."

Revenue Growth

Positive

QoQ Revenue +1.4% (Q4 $796.7M → Q1 $807.3M) and YoY Revenue +33.7% (Q1 2025 $603.6M → Q1 2026 $807.3M), indicating sustained growth with some sequential maturation.

Profitability

Good

Net Income YoY +92.3% and net margin expanded sharply to 21.0% vs 0.4% in Q4 2025. Gross margin improved to 59.1% (from 57.9%); operating margin recovered to 3.6%.

Cash Flow Quality

Neutral

Operating cash flow was -$31.5M and free cash flow -$54.6M in Q1 2026, with heavy investing/acquisition outflows (acquisitions $549.7M). This offsets earnings strength in the quarter.

Leverage & Balance Sheet

Neutral

Total assets rose to $7.07B and equity increased to $3.53B. Net debt increased to $1.37B (from $0.71B in Q4), but liquidity remains solid with $718.9M cash & short-term investments.

Shareholder Returns

Neutral

No dividends. Stock performance is negative: 1Y change -29.55% (and 6M -38.23%), so total shareholder return momentum is weak despite improved profitability.

Analyst Sentiment & Valuation

Fair

Consensus target $726.71 vs. current price $402.85 implies substantial upside on valuation, but the stock is trading well below prior levels (P/E elevated per ratio inputs).

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

AXON delivered a strong Q1 2026 with revenue of $807M (+34% YoY) and software growth at +35% YoY, powered by an AI-led acceleration. AI Era Plan bookings rose 140% YoY, while AI product revenue grew >700% YoY from a small base; management claims nearly all large domestic agencies now include AI in their purchases. Dedrone is scaling sharply: bookings +500% YoY and revenue up over 300% YoY, contributing to Platform solutions growth of 95% YoY. International is expanding quickly (international revenue >100% YoY, 20% of revenue). The company raised FY2026 revenue guidance to 30%-32% growth while maintaining a 25.5% adjusted EBITDA margin and targeting ~$450M free cash flow, despite tariff-driven cost pressure and inventory build. Q&A focused on how AI adoption ties to pipeline timing, how inventory investment affects cash conversion, and whether counter-drone/event demand is sustainable beyond showcase deployments.

AI IconGrowth Catalysts

  • AI Era Plan adoption: AI bookings up 140% YoY; management says nearly all large domestic law enforcement agencies now include AI in purchases
  • Axon software acceleration: AI product revenue growing more than 700% YoY (small base) alongside continued growth across software and services
  • Counter-drone scaling: Dedrone bookings up 500% YoY; revenue up over 300% YoY; Platform solutions (incl. counter drone hardware) grew 95% YoY
  • International expansion: international revenue up over 100% YoY and 20% of quarterly revenue
  • Enterprise penetration via Fusus + related products: $40M telecom-provider opportunity in April; deployment centers on Fusus plus Axon Body Mini and Axon Outpost; Axon Vision launching into enterprise

Business Development

  • April enterprise telecom-provider deal: $40 million opportunity; deployments centered around Fusus, plus Axon Body Mini and Axon Outpost; Axon Vision planned for enterprise rollout
  • Events used as catalysts for Dedrone awareness: protected the 2026 Super Bowl; Kentucky Derby deployment; support for American World Cup sites
  • Named technology/partner ecosystem referenced: Fusus, Dedrone, Axon 911, license plate readers, vehicle intelligence; system-integrator/distributor channels mentioned for international go-to-market (no specific distributor names)

AI IconFinancial Highlights

  • Revenue: $807M, up 34% YoY (ninth consecutive quarter above 30% growth); raised FY2026 revenue guidance to 30%-32% growth
  • Software & services: $355M, up 35% YoY; connected devices revenue $453M, up 33% YoY
  • AI product revenue: up >700% YoY; AI Era Plan bookings up 140% YoY; management expects rapid adoption as Axon 911, Axon Vision, Axon Gravity, and expanded Axon Assistant features roll into the platform
  • TASER/connected durability drivers: TASER 10 and Body 4 described as durable growth drivers
  • ARR: grew 35% YoY to $1.5B; net revenue retention 125% in the quarter
  • Future contracted bookings: $14.3B, up 44% YoY
  • Margin/guidance: FY2026 adjusted EBITDA margin expected at 25.5% (consistent with prior guidance); delivered 25% adjusted EBITDA margin in Q1
  • FFO/cash flow: targeting approximately $450M full-year 2026 free cash flow; free cash flow conversion expected to improve meaningfully despite inventory investments
  • Cost/inflation/tariffs: FY guidance incorporates continued tariffs inflationary component costs (memory and product mix shifts toward Platform solutions growth and software/services)

AI IconCapital Funding

  • Inventory investment: management sponsored a significant investment in core product inventory to hedge supply-chain risk and maximize growth (inventory described as “not solely driven by memory”)
  • CapEx: management referenced refining/tightening CapEx forecast after observing execution during the year; no specific CapEx figure provided in transcript
  • Stock-based compensation: FY2026 SBC expense expected $590M-$620M; average annual dilution expected <2.5%; performance-plan portion tied to XSP share-price/operational milestones (down vs last year)

AI IconStrategy & Ops

  • AI platform narrative: emphasis on system adoption (Axon Vision, Guardian, Assistant; Axon Gravity initiative) and how unified end-to-end workflows compound value across sensors, data, tools, and AI backbone
  • Axon Assistant scale claim: surpassed 1 million uses; “soon” available wherever officers work
  • Contract rewriting cadence: AI cross-sell accelerates contract rewrites for mid-stream customers when new products/features are launched (e.g., camera upgrades + AI urgency) to bundle into new contracts
  • Supply chain posture: minimal obsolescence risk cited due to long TASER CEW lifecycle (10-15 years) and body camera resale durability (5+ years); inventory build intended to prevent inventory constraints from limiting growth
  • Enterprise rollout sequencing: Axon Vision launching into enterprise; Draft One and Assistant described as becoming enterprise-ready

AI IconMarket Outlook

  • FY2026 revenue guidance raised to 30%-32% growth
  • FY2026 adjusted EBITDA margin guidance maintained at 25.5%
  • FY2026 free cash flow target: approximately $450M
  • Q1-to-year cash conversion framing: despite Q1 seasonal free-cash-flow softness (bonus/commission payments; one of two semiannual interest payments), management expects improvement over the next three quarters

AI IconRisks & Headwinds

  • Tariffs inflationary component costs: guidance includes memory and component cost inflation
  • Inventory investment tradeoff vs free cash flow: raised inventory for supply assurance but offsets near-term cash conversion; management relies on improved working capital and absence of certain Q1-specific outflows repeating
  • Geopolitical risk: management highlighted “geopolitical risk going into next year” and an intent to avoid international order cannibalization of U.S. shipments via sustained inventory
  • Operational constraint: management stated Dedrone demand is not opportunity-limited; it is currently constrained by ability to “get the product out the door”

Q&A: Analyst Interest

  • AI Era Plan engagement & pipeline translation: Management described Axon Week feedback as “overwhelming” across many personas; they said Axon Vision/Guardian/Brief/BriefOne/Axon Gravity features map to investigator vs command/prosecutor roles. They also linked customer trust and rapid feature releases to accelerating adoption and pipeline conversion.
  • Free cash flow confidence amid inventory & CapEx refinement: Management clarified inventory builds include memory but are primarily for supply-chain scaling and demand hedging. They argued Q1 would have been positive free cash flow absent inventory investments due to seasonal items. CapEx is refined later in the year based on execution.
  • AI bookings durability and tipping point: Management attributed AI Era Plan growth to long enterprise/multi-month sales cycles (often 8-12 months) for $50M-$200M deals. They cited a specific Mid-Atlantic city council approval for a $150M deal and emphasized ongoing engagement/ROI clarity driving rising belief.

Sentiment: POSITIVE

Note: This summary was synthesized by AI from the AXON Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Loading financial data and tables...
© 2026 Stock Market Info — Axon Enterprise, Inc. (AXON) Financial Profile